Highline Wealth Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14K Hold
10
– – ﹤0.01% 1322
2026
Q2
$1.07K Hold
10
– – ﹤0.01% 1266
2026
Q1
$1.64K Buy
10
+8
+400% +$1.23K ﹤0.01% 1086
2025
Q4
$348 Buy
+2
New +$365 ﹤0.01% 1018
2025
Q2
– Sell
-48
Closed -$3.66K – 983
2025
Q1
$3.66K Buy
+48
New +$3.67K ﹤0.01% 503

Other funds holding INSM

Highline Wealth Partners's INSM Position: Q3 2026 in Review

Highline Wealth Partners held its Insmed (INSM) position steady in Q3 2026 at 10 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Highline Wealth Partners first reported a position in INSM in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.66K in Q1 2025. 706 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Highline Wealth Partners held 10 shares of Insmed worth $1.14K as of Q3 2026.
  • Highline Wealth Partners left its Insmed share count unchanged in Q3 2026.
  • Insmed made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #1322 holding.
  • Highline Wealth Partners first reported a position in Insmed in Q1 2025 and has held it in 5 quarters since.
  • Highline Wealth Partners's Insmed position peaked at $3.66K in Q1 2025.
  • 706 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.